1[1]Weidmer N, Semple JP, Weleh WR, et al. Tumor angiogenesis and metastasis correlation in invasive breast carcinoma[J]. N Engl J Med, 1991, 324: 1.
2[2]Dvorak HF, Brown LF, Detmar M, et al. Vascual permeability factor/vascu1ar endothelial growth factor, microvascular hyperpermeability, and angiogenesis [J]. Am J Pathol, 1995, 146:1029.
3[3]Okitta S, Kondoh S, Shiraishi K, et al. Expression of vascular endothelial growth factor correlates with tumor progression in gallbladder cancer [J]. Int J Oncol, 1998, 12(5) :1013.
4[4]Yamamoto S, Fujii K, Kitadai Y, et al. Expression of vascular endothelial growth factor in human gallbladder lesions[J]. Oncol Rep,1998,5(5):1065.
5[5]Dirix LY, Vermeulen PB, Pawinski A, et al. Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients[J].Br J Cancer, 1997, 76 (2):238.
6[6]Kraft A, Weindel K, Ochs A, et al. Vascular endothelial growth factor in the sera and effusion of patients with malignant and nonmalignant disease [J]. Cancer, 1999, 85 (1):178.
7[7]Tempfer C, Ohermair A, Hefler L, et al. Vascular endothelial growth factor serum concentrations in ovarian cancer[J]. Obstet Gynecol, 1998, 92 (3): 360.
8[8]Kim KJ, Li B, Winer J, et a1. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses rumor growth in vivo[J]. Nature, 1993, 362: 841.
9[9]Millauer B, Snawver I. K, Plate KH, et al. Glioblastoma growth inhibited in vivo by a dominant-negative FLK-1 mutant[J]. Nature, 1994, 367: 576.